Gearing Up for RAD Insights From Summer Conferences

Image Credit: © maxoidos - stock.adobe.com

May is Melanoma and Skin Cancer Awareness Month, bringing the need for sun safety education throughout the summer. As patients are preparing for family vacations and summer activities, clinicians are tasked with increasing their messaging surrounding melanoma and skin cancer awareness. One aspect of patient care that remains consistently needed is skin cancer checks. With some patients, Mohs surgery may become a point of discussion after a skin check.

In this month’s issue, Nicole A. Negbenebor, MD, discusses the need to address disparities in skin cancer diagnosis and outcomes among patients of color, exemplified by a delayed melanoma diagnosis case example in a Black patient misdiagnosed before presenting with metastatic disease. Negbenebor calls for improved education on skin cancer in skin of color, culturally competent outreach, and greater diversity within Mohs surgery to enhance care for underserved populations.

Focusing on another important topic in dermatology, this month’s cover feature from Bernard Cohen, MD; and Zeena Mestari explores neuroinflammatory pathways in topical steroid withdrawal (TWS) for patients with chronic inflammatory conditions. National Institutes of Health investigators have identified neuroinflammatory changes and elevated NAD+ activity in TSW-affected skin, suggesting it may be a distinct biological entity.

As atopic dermatitis (AD) is always a prevalent condition to discuss, clinicians are encouraged to attend the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee, on June 6 and 7. RAD is now hosted by MJH Life Sciences’ Physician Education Resource (PER) group. Discussion topics at this year’s meeting include the following:

• Evaluating the efficacy, safety, and mechanisms of action of biologics, JAK inhibitors, and topical therapies.
• Applying patient-centric approaches to AD management.
• Reviewing and implementing guideline-directed care for AD.
• Using effective communication techniques to improve patient adherence and address concerns related to treatment options.

As always, Dermatology Times delivers the most up-to-date clinical content, from innovative studies and FDA approvals to exclusive interviews and expert perspectives. Stay informed with the latest data—subscribe to Dermatology Times’ e-newsletters; follow us on Facebook, LinkedIn, and X (formerly Twitter); and send ideas or contributions to DTEditor@mmhgroup.com.

To learn more about and register for RAD 2025, visit https://registration.gotoper.com/rad-2025 and use code DT40 for 40% off registration.